GWG Holdings’ Insurtech Subsidiary, Life Epigenetics, Announces Two Major Insurers to Test Lifespan-Predictive Technology

MINNEAPOLIS, Oct. 03, 2017 (GLOBE NEWSWIRE) — Life Epigenetics, the insurtech subsidiary of GWG Holdings, Inc. (Nasdaq:GWGH), announced that two major life insurance companies will begin pilot programs to test its epigenetic-based M-Panel technology.

The pilots, developed in partnership with two life insurance companies, are designed to explore how the M-Panel predictive epigenetic technology can be best applied to insurance products and services.  As part of scaling up its operational capabilities, Life Epigenetics has set up a global network of suppliers and test facilities that enable it to analyze tens of thousands of saliva samples per month. And, Life Epigenetics has established r…